Subscribe to Our Monthly Newsletters

Stay updated on trending legal insights and get our attorneys' take on the latest industry news.

Marketing by

Paul Zimmerman

Showing 5 posts from September 2021.

Photo of M&R Blog

Antartis ©

Quick Resource Guide to Foreign Corrupt Practices Act (FCPA) for Turkish Companies

Lawyers from Michelman & Robinson and Cetinkaya have authored a recently published white paper titled “FCPA for Turkish Companies.” This is a comprehensive resource guide to the Foreign Corrupt Practices Act and its application in Turkey. You can read the white paper here.

Photo of M&R Blog

JanMika ©

Delta-8 THC Is All the Rage, But Its Legality Is in the Crosshairs

Delta is very much in the news these days.

The delta variant continues to spread, bringing the total number of COVID-19 cases to 40 million since the start of the pandemic.

Delta Airlines made headlines when it recently announced that its unvaccinated employees will face $200 monthly increases on their health insurance premiums beginning November 1, citing steep costs to cover workers hospitalized with COVID.

And then there’s a delta having nothing to do with the novel coronavirus. Delta-8-tetrahydrocannabinol (THC) is a psychoactive compound naturally occurring in hemp and cannabis and believed by many to be legal at the federal level. (Read More)

Photo of M&R Blog

Ssilver ©

The Status of COVID Vaccine Mandates in the Shadow of FDA Action

For many here in the U.S., the COVID-19 vaccine remains a hot button and rather divisive issue. Some of those who have thus far refused to roll up their sleeves for inoculation have justified this decision with a common refrain: the federal government hasn’t fully approved COVID vaccines; instead, they’re only authorized for “emergency use.” This distinction has been a deal breaker for countless Americans.

But now that the Food and Drug Administration has fully approved the Pfizer-BioNTech COVID-19 vaccine, that justification no longer holds water. Not surprisingly, in the wake of the FDA’s full approval, the share of adults flat out refusing to get the vaccine has dropped by 5%—this according to a recent NPR/PBS NewsHour/Marist poll. In fact, nearly 80% of adults in the U.S. have received, or now intend to line up for, inoculation against the novel coronavirus. (Read More)

Photo of M&R Blog

Nadianb ©

New York City Council Approves Permanent Caps on Food Delivery Fees

Late last month (on August 26), the New York City Council voted to approve a bill that serves to permanently cap the commissions that third-party food delivery service providers can charge restaurants. The same bill is also intended to regulate food delivery services by requiring licensing throughout the industry. The legislation now awaits Mayor Bill de Blasio’s signature. (Read More)

Photo of M&R Blog

MrHamster ©

Optimizing the Legal Spend: A Better Approach for GCs

Notwithstanding the economic impact of COVID-19 upon businesses nationwide, corporation across industries continue to rack up some rather hefty legal bills. In fact, according to Statista, it is estimated that in 2021, large domestic companies will have spent more than $23 billion on litigation alone, up from the $22.8 billion spent in 2020.

As corporate legal fees continue to rise, GCs across the country are being asked to reduce costs. This, however, is a real challenge, especially as first-year associate compensation is becoming increasingly competitive, with many of the nation’s largest law firms offering starting salaries exceeding $200,000 (an amount that only increases as associates get promoted to more senior status). At the same time, there is an anticipated uptick in both litigation and corporate transactions as a result of the pandemic. (Read More)